2C EPOXY PRIMER ZERO IND

Hazard statements (CLP)

H225, H303+H313, H315, H317, H319, H332, H335, H350, H373

Code

Statements

H225

Highly Flammable liquid and vapour

SECTION 2: Hazards identification

Classification of the substance or mixture FLAMMABLE LIQUIDS - Category 2 ACUTE TOXICITY (oral) - Category 5 ACUTE TOXICITY (dermal) - Category 5 ACUTE TOXICITY (inhalation) - Category 4 SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 1A SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 1.5% (oral), 4.8% (dermal), 52.6% (inhalation)

Signal word

Danger

Hazard statements

H225 - Highly flammable liquid and vapor. H303 + H313 - May be harmful if swallowed or in contact with skin. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H335 - May cause respiratory irritation. H350 - May cause cancer. H373 - May cause damage to organs through prolonged or repeated exposure. (hearing organs)

Prevention

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing and eye or face protection. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P271 - Use only outdoors or in a well-ventilated area. P260 - Do not breathe vapor. P264 - Wash thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace.

Response

P308 + P313 - IF exposed or concerned: Get medical advice or attention. P304 + P340, P312 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. P301 + P312 - IF SWALLOWED: Call a POISON CENTER or doctor if you feel unwell. P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P302 + P312 - IF ON SKIN: Call a POISON CENTER or doctor if you feel unwell. P333 + P313 - If skin irritation or rash occurs: Get medical advice or attention. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.

Storage

P405 - Store locked up. P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.

Disposal

P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.

Other hazards which do not result in classification

Sanding and grinding dusts may be harmful if inhaled. Prolonged or repeated contact may dry skin and cause irritation. Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. This product contains crystalline silica which can cause lung cancer or silicosis. The risk of cancer depends on the duration and level of exposure to dust from sanding surfaces or mist from spray applications. Emits toxic fumes when heated. See toxicological information (Section 11)

2.1 Classification of the substance or mixture

FLAMMABLE LIQUIDS - Category 2 substance or mixture ACUTE TOXICITY (oral) - Category 5 ACUTE TOXICITY (dermal) - Category 5 ACUTE TOXICITY (inhalation) - Category 4 SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 1A SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 1.5% (oral), 4.8% (dermal), 52.6% (inhalation)